Congress·In Committee·H.R. 8160

Premenstrual Dysphoric Disorder Awareness and Research Act of 2026

PMDD: Research and Awareness

1 day ago·View on Congress.gov·Read full text

This bill is currently in the early stages of the legislative process and is being reviewed by the House Committee on Energy and Commerce. It was recently introduced and is considered active as it waits for further study by the committee. There are no upcoming votes or hearings scheduled at this time.

Passage Likelihood

35%Unlikely

While the bill addresses a major health issue, it currently lacks Republican cosponsors. This makes it difficult to pass in a divided Congress where bipartisan support is usually needed.

·No Republican cosponsors
·Referred to House Energy and Commerce Committee
·Focus on women's health
·Requires new federal spending

Legislative Progress

House

Senate

President

Law

Key Points

This bill aims to help people with Premenstrual Dysphoric Disorder, or PMDD. This is a serious medical condition that causes severe mood swings, depression, and physical pain before a person's period. It affects about 5 to 8 percent of women and people assigned female at birth who are of reproductive age.
The National Institutes of Health would start new research into what causes PMDD and how to treat it. They would also run clinical trials to find better medicine and care options. This research must include people from different racial and economic backgrounds to make sure the results help everyone.
The government would launch a public awareness campaign to teach people about PMDD symptoms. The goal is to reduce the shame often felt around menstrual health and help people get medical help sooner. It would also help people understand that PMDD is a real medical condition, not just bad PMS.
Doctors, nurses, and other health workers would get better training on how to diagnose PMDD. The bill provides grants to medical schools and hospitals to create special training programs. This helps providers tell the difference between PMDD and other health issues like depression or different gynecological conditions.
The Secretary of Health and Human Services would have to report back to Congress in two years. This report would show if the research is working and if more people are getting the treatment they need. The bill also asks for data on how PMDD affects the economy and the workforce.